Brazil health regulator approves emergency use of Johnson & Johnson COVID-19 vaccine

mediabest
FILE PHOTO: Vials of Johnson & Johnson’s Janssen coronavirus disease (COVID-19) vaccine candidate are seen in an undated photograph. Johnson & Johnson/Handout via REUTERS.

RIO DE JANEIRO (Reuters) – Brazil health regulator Anvisa on Wednesday said it approved emergency use of the COVID-19 vaccine developed by Johnson & Johnson subsidiary Janssen.

Source: Read Full Article

Related posts:
  1. Nigerian students design coronavirus care robot
  2. Portugal to quarantine passengers on indirect flights from UK, Brazil
  3. Brazil asks Chinese embassy for help securing extra COVID-19 vaccines: document
  4. Uruguay confirms presence of Brazilian COVID-19 variant
  5. Hungary reports record 8,312 coronavirus infections in 24 hours